|Mr. Erik Engstrom||CEO & Exec. Director||3.75M||N/A||1963|
|Mr. Nicholas Lawrence Luff||CFO & Exec. Director||2.06M||N/A||1967|
|Ms. Tracey Aiken||VP of Operations, Insurance Data Solutions & Lexisnexis Risk Solutions||N/A||N/A||N/A|
|Ms. Kumsal Bayazit Besson||Chief Exec. Officer of Scientific, Technical & Medical||N/A||N/A||N/A|
|Mr. Colin Tennant||Head of Investor Relations||N/A||N/A||N/A|
RELX PLC provides information based-analytics and decision tools for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals that enables progress in science, advance healthcare, and performance improvement. The Risk & Business Analytics segment offers information-based analytics and decision tools that combines public and industry specific content with technology and algorithms to assist in evaluating and predicting risk. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
RELX PLC’s ISS governance QualityScore as of 25 June 2019 is 2. The pillar scores are Audit: 1; Board: 3; Shareholder rights: 1; Compensation: 1.